These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Autoantibodies against dsDNA measured with nonradioactive Farr assay-an alternative for routine laboratories. Lakota K; Švec T; Kveder T; Sodin-Šemrl S; Žigon P; Ambrožič A; Ogrič M; Markez S; Božič B; Tomšič M; Čučnik S Clin Rheumatol; 2019 Feb; 38(2):353-359. PubMed ID: 30203316 [TBL] [Abstract][Full Text] [Related]
3. Comparison and evaluation of different methodologies and tests for detection of anti-dsDNA antibodies on 889 Slovenian patients' and blood donors' sera. Zigon P; Lakota K; Cucnik S; Svec T; Ambrozic A; Sodin-Semrl S; Kveder T Croat Med J; 2011 Dec; 52(6):694-702. PubMed ID: 22180268 [TBL] [Abstract][Full Text] [Related]
4. Diagnosing systemic lupus erythematosus: new-generation immunoassays for measurement of anti-dsDNA antibodies are an effective alternative to the Farr technique and the Crithidia luciliae immunofluorescence test. Antico A; Platzgummer S; Bassetti D; Bizzaro N; Tozzoli R; Villalta D; Lupus; 2010 Jul; 19(8):906-12. PubMed ID: 20179169 [TBL] [Abstract][Full Text] [Related]
5. Anti-dsDNA antibody testing by Farr and ELISA techniques is not equivalent. Neogi T; Gladman DD; Ibanez D; Urowitz M J Rheumatol; 2006 Sep; 33(9):1785-8. PubMed ID: 16924691 [TBL] [Abstract][Full Text] [Related]
6. Changes in Farr radioimmunoassay and EliA fluorescence immunoassay anti-dsDNA in relation to exacerbation of SLE. Hillebrand JJ; Bernelot Moens HJ; Mulder AH Lupus; 2013 Oct; 22(11):1169-73. PubMed ID: 23929638 [TBL] [Abstract][Full Text] [Related]
7. Anti-double stranded DNA antibodies in systemic lupus erythematosus: detection and clinical relevance of IgM-class antibodies. Bootsma H; Spronk PE; Hummel EJ; de Boer G; ter Borg EJ; Limburg PC; Kallenberg CG Scand J Rheumatol; 1996; 25(6):352-9. PubMed ID: 8996469 [TBL] [Abstract][Full Text] [Related]
9. Anti-dsDNA antibody assay: high specificity and sensitivity with a filtration radioassay in comparison to low specificity with the standard ELISA. Yu L; Wang J; O'Dell JR; Oates J; Arend WP; Eisenbarth GS J Rheumatol; 2007 Apr; 34(4):734-9. PubMed ID: 17407230 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the Farr radioimmunoassay, 3 commercial enzyme immunoassays and Crithidia luciliae immunofluorescence test for diagnosis and activity assessment of systemic lupus erythematosus. Launay D; Schmidt J; Lepers S; Mirault T; Lambert M; Kyndt X; Reumaux D; Duhamel A; Hachulla E; Hatron PY; Prin L; Dubucquoi S Clin Chim Acta; 2010 Jul; 411(13-14):959-64. PubMed ID: 20303931 [TBL] [Abstract][Full Text] [Related]
11. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus. Bardin N; Desplat-Jego S; Daniel L; Jourde Chiche N; Sanmarco M Autoimmunity; 2009 Jan; 42(1):63-8. PubMed ID: 19127456 [TBL] [Abstract][Full Text] [Related]
12. Auto-antibodies to double-stranded DNA as biomarker in systemic lupus erythematosus: comparison of different assays during quiescent and active disease. de Leeuw K; Bungener L; Roozendaal C; Bootsma H; Stegeman CA Rheumatology (Oxford); 2017 May; 56(5):698-703. PubMed ID: 28053277 [TBL] [Abstract][Full Text] [Related]
13. Clinical significance of anti-nDNA antibodies in ANA-positive systemic lupus erythematosus: comparison of the Farr radioimmunoassay and the Crithidia luciliae immunofluorescent technique. Chuan MT; Wu YC; Ang ET; Wang JH; In KL; Lü YC Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1985 Feb; 18(1):15-24. PubMed ID: 3896689 [TBL] [Abstract][Full Text] [Related]
14. The clinical significance of measuring different anti-dsDNA antibodies by using the Farr assay, an enzyme immunoassay and a Crithidia luciliae immunofluorescence test. Werle E; Blazek M; Fiehn W Lupus; 1992 Dec; 1(6):369-77. PubMed ID: 1304405 [TBL] [Abstract][Full Text] [Related]
15. A comparison between the Farr radioimmunoassay and a new automated fluorescence immunoassay for the detection of antibodies against double stranded DNA in serum. Derksen RH; Bast EJ; Strooisma T; Jacobs JW Ann Rheum Dis; 2002 Dec; 61(12):1099-102. PubMed ID: 12429543 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of ELISA positive and immunofluorescence negative anti-dsDNA antibody. Kim KH; Han JY; Kim JM; Lee SW; Chung WT Clin Chim Acta; 2007 May; 380(1-2):182-5. PubMed ID: 17355877 [TBL] [Abstract][Full Text] [Related]
17. Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis. Jaekell HP; Trabandt A; Grobe N; Werle E Lupus; 2006; 15(6):335-45. PubMed ID: 16830879 [TBL] [Abstract][Full Text] [Related]
18. Histone-containing immune complexes are to a large extent responsible for anti-dsDNA reactivity in the Farr assay of active SLE patients. Hylkema MN; van Bruggen MC; ten Hove T; de Jong J; Swaak AJ; Berden JH; Smeenk RJ J Autoimmun; 2000 Mar; 14(2):159-68. PubMed ID: 10677247 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays. An Italian multicentre study. Ghirardello A; Villalta D; Morozzi G; Afeltra A; Galeazzi M; Gerli R; Mathieu A; Meroni PL; Pregnolato F; Migliorini P; Radice A; Riccieri V; Ruffatti A; Sebastiani GD; Sinico RA; Tincani A; Doria A; Clin Exp Rheumatol; 2011; 29(1):50-6. PubMed ID: 21345292 [TBL] [Abstract][Full Text] [Related]
20. Anti-dsDNA-NcX ELISA: dsDNA-loaded nucleosomes improve diagnosis and monitoring of disease activity in systemic lupus erythematosus. Biesen R; Dähnrich C; Rosemann A; Barkhudarova F; Rose T; Jakob O; Bruns A; Backhaus M; Stöcker W; Burmester GR; Schlumberger W; Egerer K; Hiepe F Arthritis Res Ther; 2011 Feb; 13(1):R26. PubMed ID: 21329504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]